Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LUND, I. M.
Right arrow Articles by KNUDSEN, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LUND, I. M.
Right arrow Articles by KNUDSEN, E. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1979 British Society for Rheumatology

research-article

PERSISITENT LOCAL CUTANEOUS ATROPHY FOLLOWING CORTICOSTEROID INJECTION FOR TENDINITIS

INGER MARSTRAND LUND1, RENÈ DONDE and ERICK A. KNUDSEN

Department of Physical Medicine and Rehabilitation, Sunby Hospital and Dermatologic Department, Kobenhavns Komoues Hospital I Hvidovre Copenhagen, Denmark

Correspondence to: Requests for reprints to Dr. Inger Marstrand Lund, Bag Sondermarken 1 A, 2500 Valby Copenhagen, Denmark.

A 21-year-old female, treated with triamcinolone for tendinitis in the oblique muscles of both forearms, developed a skin atrophy, localized around the injection points.

The patient was followed over a period of more than five years during which a partial remission of the skin changes was observed.

A synopsis covering local use of steroids for various diseases is given.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.